What question did this study set out to answer?

To review the updated 2018 European Society of Cardiology guidelines for assessing, stratifying, and managing cardiovascular disease in pregnant women to optimize maternal and fetal health.

February 2, 2026Srce i krvni sudoviOpen Access

Management of the cardiovascular disease during pregnancy in the light of 2018 ESC Guidelines

Q: What is the clinical evidence from this study?

Population: cardiovascular diseases during pregnancy. Primary outcome: risk assessment in women with cardiac diseases of childbearing age.

View Full Paper

Ask AI

Bookmark

Key result

2018 ESC guidelines recommend a multidisciplinary approach for managing high-risk CV disease during pregnancy.

Key Points

To review the updated 2018 European Society of Cardiology guidelines for assessing, stratifying, and managing cardiovascular disease in pregnant women to optimize maternal and fetal health.
Summarized consensus recommendations from the 2018 European Society of Cardiology (ESC) Task Force on managing maternal cardiovascular conditions.
Evaluated preconception risk stratification using the modified World Health Organization (mWHO) classification, pregnancy heart teams, and drug safety profiles.
Maternal disease complicates 1–4% of pregnancies, with severe systemic ventricular dysfunction (EF <30% or NYHA class III–IV) and pulmonary arterial hypertension designated as mWHO class IV contraindicating pregnancy.
Delivery planning is recommended at 20–30 weeks of pregnancy with induction considered at 40 weeks, prioritizing vaginal delivery over caesarean sections for most cardiac patients.
Antihypertensive treatment is advised for persistent blood pressure ≥ 150/95 mmHg or >140/90 mmHg with gestational complications, alongside 100–150 mg of daily acetylsalicylic acid from week 12 to week 36–37 for pre-eclampsia prevention.

PICO

Population

cardiovascular diseases during pregnancy

Primary Outcome

risk assessment in women with cardiac diseases of childbearing age

Limitations

Lack of details on specific clinical outcomes and exact study results due to the nature of guidelines review.

Implication

Supports guideline-aligned multidisciplinary care now; leaves open prospective validation of outcomes.

Abstract

The article does not contain abstract.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Trifunovic-Zamaklar et al. (2019) studied cardiovascular diseases during pregnancy. The 2018 ESC guidelines emphasize risk assessment and management of cardiovascular diseases during pregnancy, recommending a multidisciplinary approach for high-risk patients.

synapsesocial.com/papers/6980fe48c1c9540dea810310 https://doi.org/10.5937/siks1901038t

View Full Paper

Ask AI

Bookmark

Implication

Supports guideline-aligned multidisciplinary care now; leaves open prospective validation of outcomes.

Abstract

The article does not contain abstract.

Management of the cardiovascular disease during pregnancy in the light of 2018 ESC Guidelines

Key Points

PICO

Limitations

Implication

Abstract

Discussion

Cite This Study

Management of the cardiovascular disease during pregnancy in the light of 2018 ESC Guidelines

Key Points

PICO

Limitations

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading